About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
Previous Close | $18.03 | Open | |
Volume | Market Cap | 1.403B | |
Yield | Last Dividend |
Portola Pharmaceuticals : Amendment to a... | 06/30/20 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 ??? | June 30, 2020 |
Portola Pharmaceuticals Announces Virtua... | 05/18/20 |
SOUTH SAN FRANCISCO, Calif., May 18, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.?? (NASDAQ: PTLA) today announced that, due to the public healt... |
U.S. Centers for Medicare & Medicaid Ser... | 05/14/20 |
SOUTH SAN FRANCISCO, Calif. , May 14, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ?? (NASDAQ: PTLA ) announced that the U.S. Centers for Medica... |
Portola Pharmaceuticals Reports First Qu... | 05/11/20 |
SOUTH SAN FRANCISCO, Calif., May 11, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.?? (Nasdaq: PTLA) today reported financial results for the thre... |
ALEXION ACQUIRES PORTOLA PHARMACEUTICALS... | 05/05/20 |
Alexion Pharmaceuticals (NASDAQ: ALXN) has announced it is acquiring Portola Pharmaceuticals (NASDAQ: PTLA) for $1.41 billion in cash. Founded in 2003... |
Alexion to buy Portola Pharma for $1.4B | 05/05/20 |
Alexion will pay $18 per share for Portola, which closed at $7.76 per share on Monday. |
Portola's stock more than doubles on hea... | 05/05/20 |
Shares of Portola Pharmaceuticals Inc. undefined more than doubled in very active morning trading Tuesday, after the biopharmaceutical company focused... |
What You Should Know About Alexion's $1.... | 05/05/20 |
Large-cap biopharma Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) announced a deal Tuesday to buy its small-cap peer Portola Pharmaceuticals Inc (NASD... |
Alexion Pharmaceuticals (ALXN) to acquir... | 05/05/20 |
Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (N... |
Alexion to buy Portola Pharmaceuticals i... | 05/05/20 |
Drugmaker Alexion Pharmaceuticals Inc on Tuesday agreed to buy Portola Pharmaceuticals Inc in a deal that values its smaller rival at $1.41 billion to... |
Portola Pharmaceuticals Announces Result... | 03/16/20 |
SOUTH SAN FRANCISCO, Calif., March 16, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.?? (Nasdaq: PTLA) today announced new data reinforcing the va... |
DEADLINE ALERT: Bragar Eagel & Squire, P... | 03/11/20 |
NEW YORK--(BUSINESS WIRE)-- #PTLA--Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action la... |
The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... |
PTLA DEADLINE ALERT - Bronstein, Gewirtz... | 03/09/20 |
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Portola Pharmaceut... |
ROSEN, NATIONAL TRIAL COUNSEL, Reminds P... | 03/08/20 |
NEW YORK, March 08, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Portola Pharmaceuticals, Inc. b... |
Shareholder Alert: Robbins LLP Announces... | 03/03/20 |
SAN DIEGO & SAN FRANCISCO--(BUSINESS WIRE)---- $PTLA #ClassAction--Shareholders Rights law firm Robbins LLP announces that another purchaser of Portol... |
The Daily Biotech Pulse: GenMark Diagnos... | 03/03/20 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) ... |
Glancy Prongay & Murray LLP Announces th... | 03/02/20 |
LOS ANGELES--(BUSINESS WIRE)---- $PTLA #classaction--Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Portol... |
The Daily Biotech Pulse: Gilead Kicks Of... | 02/27/20 |
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... |
Portola Pharmaceuticals Reports Fourth Q... | 02/26/20 |
SOUTH SAN FRANCISCO, Calif. , Feb. 26, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ?? (NASDAQ: PTLA ) today reported financial results for the ... |
ROSEN, A LEADING INVESTOR FIRM, Reminds ... | 02/15/20 |
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) between May 8, |
Portola Pharmaceuticals to Announce Four... | 02/12/20 |
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc.?? (NASDAQ: PTLA) today announced that it will host a webcast ... |
Portola Pharmaceuticals Appoints Rajiv P... | 02/03/20 |
Portola Pharmaceuticals, Inc.?? (Nasdaq: PTLA) today announced the appointment of Rajiv Patni, M.D., as executive vice president and chief medical off... |
The Law Offices of Frank R. Cruz Reminds... | 01/30/20 |
LOS ANGELES--(BUSINESS WIRE)---- $PTLA #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming March 16, 2020 deadline to fil... |
The Daily Biotech Pulse: Acceleron's Pos... | 01/28/20 |
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) ... |
Zhang Investor Law Announces Securities ... | 01/22/20 |
NEW YORK, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought sha... |
ROSEN, A TOP RANKED LAW FIRM, Announces ... | 01/21/20 |
NEW YORK , Jan. 21, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf o... |
PTLA LOSSES ALERT: Bernstein Liebhard LL... | 01/17/20 |
Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors th... |
PTLA LOSSES ALERT: Bernstein Liebhard LL... | 01/17/20 |
NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been file... |
The Law Offices of Frank R. Cruz Announc... | 01/17/20 |
LOS ANGELES--(BUSINESS WIRE)---- $PTLA #classaction--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf o... |
Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
Total Revenue | $1.3B | Total Liabilities | $2.1B |
Cost of Revenue | $2.5B | Total cash flow | $3.2 |
Total Assets | $29.98B |
% Insider | 12.52% | % Institutional | 76.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Service Name | Trader | % Success | |
---|---|---|---|
Alpha Swing Trades | Jonathan | 68.00 % | Follow |
Spread and Condor Play | Sankar | 65.00 % | Subscribe |
TopFlight Trades - Short Plays | Eric Cunningham | 40.00 % | Follow |
Symmetry Options | Symmetry Options | 33.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.